NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-138-1994-0-US-06 CARTILAGE-DERIVED MORPHOGENETIC PROTEINS US CON 10/379,830 7220558 Abandoned PDF
NCI E-289-1999-0-US-07 1,8-Naphthalimide Imidazo[4,5,1-de] acridones with Anti-Tumor Activity US National Stage 10/221,236 6664263 Abandoned PDF
NIDA E-086-2005-0-US-01 Use Of Buprenorphine Adn Naloxone For Treating Alcoholism US 60/319,988 Abandoned
CC E-348-2001-0-US-02 Image Guided Liver Intervetnions Based on Magnetic Tracking of Internal Organ Motion US ORD 10/377,528 Abandoned
NIAID E-185-2003-0-US-01 Assays For Assembly Of Ebola Virus Nucleocapsids US 60/451,317 Abandoned
NIAID E-093-2003-0-US-01 Recovery of Recombinant Human Metapneumovirus (HPMV) From CDNA and Use of Recombinant HMPV in Immunogenic Compositions and As Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens US 60/451,119 Abandoned
NICHD E-113-2002-0-US-01 Method for Preparing 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione Intermediates thereof and Methods for the Preparation of Such Intermediates US 60/451,096 Abandoned
NCI E-073-2003-0-US-01 Composition And Method Of Use Of Compounds Which Inhibit Protein Kinase C Through Inactivation Of The C1 Domains In Their Regulatory Region US 60/451,214 Abandoned
NCI E-057-2002-2-PCT-01 Conjugates of Ligand, Linker and Cytotoxic Agent and Related Compositions and Methods of Use PCT PCT COMB PCT/US03/06344 Expired
NCI E-060-2002-2-PCT-01 DNA-BINDING POLYAMIDE DRUG CONJUGATES PCT PCT COMB PCT/US03/06006 Expired
NCI E-130-2003-0-US-01 Magnetic Resonance Imaging Guidance for High-Dose Rate Brachytherapy of the Prostate US 60/449,850 Abandoned
NCI E-134-2004-0-US-01 Pharmaceutical Composition For Treatment Of Drug Dependencef US 60/449,868 Abandoned
NCI E-147-2003-0-US-01 Identification of Nucelotide Variants using Comparative Fluorometric Hybridization with Reference and Variant Oligonucleotides US 60/451,053 Abandoned
NIDDK E-096-2002-0-AU-04 Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity AU National Stage 2003212459 Abandoned
NIMH E-002-2004-0-PCT-02 Trans-Splicing Mediated Photodynamic Therapy PCT PCT PCT/US2003/005615 Expired
NIDDK E-096-2002-0-PCT-02 Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity PCT PCT PCT/US03/06115 Expired
NIMH E-002-2004-0-US-03 Trans-Splicing Mediated Photodynamic Therapy US ORD 10/374,784 Abandoned
NIDDK E-253-1999-1-US-06 Methods for Treating Glaucoma US DIV 10/374,003 Abandoned
NIDDK E-096-2002-0-EP-03 An Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity EP National Stage 03709399.4 Abandoned
NIDDK E-096-2002-0-CA-05 Obligate Domain-Swapped Dimer of Cyanovirin With Enhanced Anti-Viral Activity CA National Stage 2477408 Abandoned
NCI E-230-2002-1-US-01 Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificiites, Domains, That Promote In Vitro Protein Folding, And Methods For Their Use US 60/450,250 Abandoned
NCI E-137-2007-0-US-01 Methods For Delivering Angiogenic Modulators Using Pox Viruses US 60/449,720 Abandoned
NIDA E-087-2002-0-CA-05 Methods For Preventing or Treating Cardiac Arrhythmia CA National Stage 2476996 Abandoned
NIDA E-087-2002-0-EP-04 Methods For Preventing or Treating Cardiac Arrhythmia EP National Stage 03713563.9 Expired
NIDA E-087-2002-0-AU-06 Methods for Preventing or Treating Cardiac Arrythmia AU National Stage 2003217607 Abandoned
NCI E-253-1993-0-US-10 Self-Assembling Recombinant Papillomavirus Capsid Proteins US CON 10/371,846 7220419 Abandoned PDF
NIDCD E-264-1997-0-AU-14 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS AU DIV 2003200964 Abandoned
NIDA E-087-2002-0-PCT-03 Methods For Preventing or Treating Cardiac Arrhythmia PCT PCT PCT/US03/05138 Expired
NIAID E-227-2001-0-PCT-02 Brother of The Regulator of Imprinted Sites (BORIS) PCT PCT PCT/US2003/05186 Expired
CC E-078-2002-0-PCT-02 Refinement if Isointensity Surfaces PCT PCT PCT/US03/005268 Expired
NCI E-087-2004-0-US-01 Pharmaceutical Compositions of Safingol and Methods of Use of the Same US 60/444,536 Abandoned
NIA E-204-2003-0-US-01 Hexahydropyrrlol [2,3-b] Indole Analogues That Alter The Processing Of Alzheimer's Disease Protein, Amyloid Precursor Protein, To Lower Amyloid-beta Peptide Levels US 60/449,295 Abandoned
NCI E-028-2007-0-US-01 Novel Insertion Sites In Pox Vectors US 60/448,591 Abandoned
NHLBI E-120-2003-0-US-01 Method of inducing B cell apoptosis. US 60/449,056 Abandoned
NIAID E-304-2004-0-US-03 Sequence Analysis Of The Tetravalent Rotavirus Vaccine US ORD 10/505,818 7485415 Abandoned PDF
NIAID E-304-2004-0-PCT-02 Sequence Analysis Of The Tetravalent Rotavirus Vaccine PCT PCT PCT/US03/05172 Abandoned
NIEHS E-034-2002-0-PCT-02 Mutated Constitutively Active Nuclear Orphan Receptor PCT PCT PCT/US03/05163 Expired
NIAID E-225-2000-0-CN-07 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes CN National Stage 01814362.8 Abandoned
NIAID E-304-2004-0-EP-04 Sequence Analysis Of The Tetravalent Rotavirus Vaccine EP National Stage 03709213.7 Abandoned
NCI E-003-2003-0-US-01 AMPLIFICATION OR OVEREXPRESSION OF MLL SEPTIN-LIKE FUSION (MSF) AND SEPTIN9 AND METHODS RELATED THERETO12 US 60/448,700 Abandoned
NHLBI E-080-2002-0-US-04 Modified Defensins And Their Use US DIV 12/388,427 8106006 Expired PDF
NIMH E-088-2002-0-JP-02 Multi-dimensional Liquid Chromatography Separation System JP National Stage 2003-039107 Expired
NHLBI E-080-2002-0-PCT-02 Modified Defensins And Their Use PCT PCT PCT/US03/04649 Expired
NCI E-057-2002-2-EP-03 Conjugates of Ligand, Linker and Cytotoxic Agent and Related Compositions and Methods of Use EP National Stage 03721323.8 Abandoned
NCI E-082-2003-0-US-01 METHOD AND MATERIALS FOR PROMOTING MIGRATION OF T CELLS TO THE VASCULATURE OF A TUMOR US 60/447,497 Abandoned
NCI E-090-1994-0-IT-12 NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MALARIA IT EP 95910230.2 Abandoned
NCI E-090-1994-0-IE-09 NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MALARIA IE EP 95910230.2 Abandoned
NCI E-090-1994-0-DE-10 NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MALARIA DE EP 95910230.2 Abandoned
NCI E-090-1994-0-FR-11 NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MALARIA FR EP 95910230.2 Abandoned
NCI E-090-1994-0-GB-08 NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MALARIA GB EP 95910230.2 Abandoned